USPTO serial 77213562
IDENIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 19, 2008
- Examiner
- TANNER, MICHAEL R
- Law office
- TMO LAW OFFICE 117
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with IDENIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
CAMBRIDGE, MA
Cambridge, MA
Cambridge, MA
Cambridge, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James A. Thomas
James A. Thomas Merck & Co., Inc.126 E. Lincoln AvenueOffice of General CounselRahway, NJ 07065Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of infectious diseases | SECTION 8 - CANCELLED | Nov 15, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IDENIX PHARMACEUTICALS LLC
- Other trademarks owned by Idenix Pharmaceuticals, Inc.
- Other trademarks owned by Idenix Pharmaceuticals, Inc.
- Other trademarks owned by Idenix Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Similar marks named IDENIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2018 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Mar 15, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 19, 2017 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 7, 2015 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 10, 2014 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 9, 2014 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 9, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 6, 2014 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Jan 6, 2014 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 19, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 4, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 14, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 26, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 26, 2007 | ALIE | ASSIGNED TO LIE | — |
| Sep 25, 2007 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Sep 25, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 25, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 24, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 27, 2007 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Jun 26, 2007 | NWAP | NEW APPLICATION ENTERED | — |